Latest AI Stock Forecasts - All Predictions

Signal date 2026-10-14 Cut-offs from the 2026-10-13 run

Companies scored 2487 IC ≥ 0 · market cap ≥ $100M

Median forecast +1.01% Total · 30D

Long–short spread +2.21% Strong Buy minus Strong Sell, mean

Median IC 0.29 Spearman · 30D

Rating changes ▲ 91 ▼ 70 vs the previous run

Cross-section

Distribution of the day's forecasts

30D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).

-1.2% 0 +2.4%

Signals · All

288 companies

Sorted by market cap ↓ · forecast rankings are part of the paid plans

#	Ticker	Sector	IC	Mkt cap	Rating	30D	90D	Δ
101	URGNUroGen Pharma Ltd.	Life Sciences	0.44	$1.9B	Unlock rating and forecasts
102	XNCRXencor Inc	Life Sciences	0.46	$1.9B	Unlock rating and forecasts
103	XERSXeris Biopharma Holdings, Inc.	Life Sciences	0.21	$1.9B	Unlock rating and forecasts
104	MLYSMineralys Therapeutics, Inc.	Life Sciences	0.28	$1.9B	Unlock rating and forecasts
105	XTLBXTL BIOPHARMACEUTICALS LTD	Life Sciences	0.15	$1.8B	Unlock rating and forecasts
106	AGIOAGIOS PHARMACEUTICALS, INC.	Life Sciences	0.02	$1.8B	Unlock rating and forecasts
107	VIRVir Biotechnology, Inc.	Life Sciences	0.54	$1.8B	Unlock rating and forecasts
108	TRVITrevi Therapeutics, Inc.	Life Sciences	0.31	$1.8B	Unlock rating and forecasts
109	SRPTSarepta Therapeutics, Inc.	Life Sciences	0.25	$1.7B	Unlock rating and forecasts
110	ZBIOZenas BioPharma, Inc.	Life Sciences	0.19	$1.7B	Neutral	+1.08%	+4.57%	·
111	SEPNSepterna, Inc.	Life Sciences	0.10	$1.7B	Unlock rating and forecasts
112	MRVIMARAVAI LIFESCIENCES HOLDINGS, INC.	Life Sciences	0.62	$1.7B	Unlock rating and forecasts
113	NTLAIntellia Therapeutics, Inc.	Life Sciences	0.48	$1.7B	Unlock rating and forecasts
114	NUVBNuvation Bio Inc.	Life Sciences	0.35	$1.7B	Unlock rating and forecasts
115	ANIPANI PHARMACEUTICALS INC	Life Sciences	0.46	$1.6B	Unlock rating and forecasts
116	OCULOCULAR THERAPEUTIX, INC	Life Sciences	0.15	$1.6B	Unlock rating and forecasts
117	GENBGenerate Biomedicines, Inc.	Life Sciences	0.10	$1.6B	Unlock rating and forecasts
118	CMPSCOMPASS Pathways plc	Life Sciences	0.14	$1.5B	Unlock rating and forecasts
119	ETONEton Pharmaceuticals, Inc.	Life Sciences	0.13	$1.5B	Unlock rating and forecasts
120	INVAInnoviva, Inc.	Life Sciences	0.42	$1.5B	Neutral	+0.81%	+1.21%	·
121	PAHCPHIBRO ANIMAL HEALTH CORP	Life Sciences	0.47	$1.5B	Neutral	+0.76%	+2.51%	·
122	MAZEMaze Therapeutics, Inc.	Life Sciences	0.30	$1.5B	Unlock rating and forecasts
123	RAREUltragenyx Pharmaceutical Inc.	Life Sciences	0.36	$1.5B	Unlock rating and forecasts
124	STOKStoke Therapeutics, Inc.	Life Sciences	0.39	$1.5B	Unlock rating and forecasts
125	PCRXPacira BioSciences, Inc.	Life Sciences	0.31	$1.4B	Neutral	+0.87%	+1.88%	·
126	CBIOGYRE THERAPEUTICS, INC.	Life Sciences	0.12	$1.4B	Unlock rating and forecasts
127	IMCRImmunocore Holdings plc	Life Sciences	0.12	$1.4B	Neutral	+1.01%	+3.03%	·
128	RAPPRapport Therapeutics, Inc.	Life Sciences	0.14	$1.4B	Unlock rating and forecasts
129	OMEROMEROS CORP	Life Sciences	0.46	$1.4B	Neutral	+1.08%	+3.84%	·
130	QUREuniQure N.V.	Life Sciences	0.37	$1.3B	Neutral	+0.93%	+2.08%	·
131	ANABANAPTYSBIO, INC	Life Sciences	0.56	$1.3B	Neutral	+0.85%	+3.05%	·
132	NKTRNEKTAR THERAPEUTICS	Life Sciences	0.35	$1.3B	Unlock rating and forecasts
133	SNDXSyndax Pharmaceuticals Inc	Life Sciences	0.00	$1.2B	Neutral	+1.09%	+3.48%	·
134	GHRSGH Research PLC	Life Sciences	0.05	$1.2B	Unlock rating and forecasts
135	TSHATaysha Gene Therapies, Inc.	Life Sciences	0.19	$1.2B	Unlock rating and forecasts
136	REPLReplimune Group, Inc.	Life Sciences	0.37	$1.1B	Unlock rating and forecasts
137	AMPHAmphastar Pharmaceuticals, Inc.	Life Sciences	0.47	$1.1B	Unlock rating and forecasts
138	TYRATyra Biosciences, Inc.	Life Sciences	0.23	$1.1B	Unlock rating and forecasts
139	OPKOPKO HEALTH, INC.	Life Sciences	0.01	$985M	Unlock rating and forecasts
140	MNKDMANNKIND CORP	Life Sciences	0.57	$981M	Unlock rating and forecasts
141	QDELQuidelOrtho Corp	Life Sciences	0.20	$967M	Unlock rating and forecasts
142	MGTXMeiraGTx Holdings plc	Life Sciences	0.10	$955M	Unlock rating and forecasts
143	IMTXImmatics N.V.	Life Sciences	0.26	$916M	Unlock rating and forecasts
144	CGEMCullinan Therapeutics, Inc.	Life Sciences	0.50	$907M	Unlock rating and forecasts
145	RIGLRIGEL PHARMACEUTICALS INC	Life Sciences	0.20	$881M	Neutral	+1.08%	+3.99%	·
146	ANROAlto Neuroscience, Inc.	Life Sciences	0.19	$867M	Unlock rating and forecasts
147	CYRXCryoport, Inc.	Life Sciences	0.39	$858M	Unlock rating and forecasts
148	ALMSALUMIS INC.	Life Sciences	0.49	$849M	Unlock rating and forecasts
149	GLUEMonte Rosa Therapeutics, Inc.	Life Sciences	0.23	$844M	Unlock rating and forecasts
150	ABUSArbutus Biopharma Corp	Life Sciences	0.03	$813M	Unlock rating and forecasts

Breadth

By sector

Median 30D forecast per sector. Click to filter.

Finance or Crypto Assets36 +1.7% Life Sciences288 +1.3% Technology337 +1.1% Manufacturing424 +1.1% Trade & Services324 +1.0% Industrial Applications and Services256 +1.0% Real Estate & Construction207 +0.9% Finance351 +0.9% Energy & Transportation256 +0.9%

Since the previous run

Rating changes

▲ 91▼ 70

Which companies were upgraded or downgraded is part of the paid plans.

Next step

Unlock the full ranking

Every company's rating, its 30- and 90-day forecasts, the forecast and IC-weighted rankings, the daily rating changes and CSV export.

See plans Create a free account

Methodology

Ratings are relative: the forecasts of the latest complete daily run (2026-10-13) are ranked and cut at the 15th, 35th, 65th and 85th percentiles, so Strong Sell is the bottom 15%, Sell the next 20%, Neutral the middle 30%, Buy the next 20% and Strong Buy the top 15%. Expected absolute price move over the horizon, market included. This is the number a price target is built from. IC is the company's Spearman information coefficient between its past forecasts and the realised returns at the selected horizon; IC-weighted ranking multiplies each forecast by its IC (negative IC counts as zero). Δ is the rating move since the company's previous signal, in rating steps. Each company shows its latest signal, including one from a run still in progress; every signal is rated against the cut-offs above. Quantitative research output, not investment advice.

Daily Signals

Distribution of the day's forecasts

288 companies

By sector

Rating changes

Unlock the full ranking

Intratio Assistant

Cookie Settings

Essential Cookies

Analytics Cookies

Daily Signals

Distribution of the day's forecasts

288 companies

By sector

Rating changes

Unlock the full ranking